In an open, randomized, parallel group study of 84 adult patients undergoing elective day-case urological surgery the specific benzodiazepine antagonist flumazenil was shown to reverse effectively subjective postoperative sedation due to midazolam and enabled 83% of patients to recover and be ready for potential discharge within 15 min of surgery (control group 24% p <0.001). The significantly shorter recovery time has benefits in terms of increased patient cooperation and reduced demands on postoperative nursing care. The implications of these findings for day-case surgery are discussed.
Introduction
The Royal College of Surgeons of England has sought to encourage the practice of day-case surgery and regards it as an important and cost-effective element in surgical care'. Guidelines drawn up by the College estimate that up to 37% of all general surgical and urological procedures currently carried out on an inpatient basis could be performed safely as day cases.
However. day-case surgery is not without its own problems many of which centre around the practical difficulties associated with the prolonged recovery times which may be encountered if techniques other than simple local anaesthetic infiltration are used. As a result, the use of nursing staff and available beds is often less than optimal.
General anaesthesia is never a minor procedure. In this respect further limitations are imposed on patients and, in general, only those patients under 65 years of age and ASA Grade I or II are suitable candidates for day-case general anaesthesia'. Such problems may combine to deter even the most enthusiastic surgeon especially in those specialties where there exists a significant proportion of elderly patients.
The ideal technique for day-case surgery is one which renders patients amenable to both open and endoscopic procedures whilst at the same time providing rapid postoperative recovery and a wide margin of safety independent of patient selection.
The use of sedatives to complement local analgesia can improve patient tolerance of these procedures. Such techniques are not new 2 • More recently, our departments have employed preoperative intramuscular midazolam (providing sedation and anxiolysis) with local analgesia (lignocaine) in a technique referred to as sedoanalgesia -the name emphasizing the twin components of the technique". Despite the short duration of action of midazolam, postoperative recovery may still be longer than is desirable in the context of a day-case surgical ward.
Flumazenil is a novel benzodiazepine antagonist'. It allows for the safe, rapid and effective reversal of sedation produced by the administration of benzodiazepines. As such, it has considerable potential in day-case surgery. We report here on the results of an open, randomized, parallel group study conducted to assess the efficacy and potential of flumazenil in day-case urological surgery performed under sedoanalgesia.
Patients and methods
Eighty-four adults scheduled for day-case urological surgery were entered into an open, randomized, parallel group study. The trial protocol was approved by the hospital Ethical Committee. All patients gave informed consent prior to entry into the study. Patients were randomized on the basis of their hospital numbers (odd vs even) and allocated into one of two groups for study. Exclusion criteria included sensitivity to benzodiazepines, a history of hepatic or renal disease. pregnancy and current use of psychotropic drugs. All patients received intramuscular midazolam (approximately 0.1 mg/kg with appropriate reductions for elderly and unfit patients) as a premedication administered 40 min preoperatively followed by 2% lignocaine gel to the urethra (males)or 4% lignocaine spray to the perineum (females). Details of the sedoanalgesic technique are referred to elsewhere". Postoperatively group A patients (n=38) had no further drug administration whilst group B patients (n=46) received flumazenil 0.5 mg intravenously as a bolus injection.
A 10 em visual analogue scale was used to provide a quantitative assessment of the pain experienced by patients. Assessments were carried out at two points -preoperatively, related to the intramuscular injection of midazolam and postoperatively, related to the surgical procedure performed.
Amnesia was assessed postoperatively by asking patients to recall standard details of their operative experience from premedication to recovery. In this way, amnesia was rated as either complete/partial or absent (ie, full recall).
On return to the ward, patient recovery was assessed subjectively by trained nursing staff blind to any treatment the patient had received. Patients were adjudged recovered when, in the opinion of the senior nurse in charge of the day-case ward. they were safe for discharge. The time taken for patients to reach this point was measured in minutes. It should be stressed that such patients were not actually discharged at this time but kept under observation for a further 1-2 h prior to departure from the unit in the company of a responsible adult.
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Data was analysed using Fisher's exact test for unpaired data to establish the significance of differences between the two study groups. Analysis of variance (ANOVA) was used to establish the interaction between intervention, treatment group and time (pre/postoperative) with respect to pain scores.
Results
Both patient groups were comparable with respect to demographic characteristics (Table 1) . Analysis ofthe procedural details ( Table 2) shows that groups A and B received similar mean doses ofmidazolam (6.9 mg vs 6.65 mg respectively) and that the time elapsing from injection of midazolam to the onset of surgery was not significantly different (39.3 min vs 38 min).
Flumazenil was administered at an average time of 44.8 min following intramuscular injection of midazolam to patients in group B.
There were no significant differences between groups A and B in respect of completeness of amnesia or pain scores both pre-and postoperatively ( Table 3) . In this situation operative intervention was not a significant factor on analysis of variance.
Group A (n= 38)

Group B (n=46)
Between groups difference
Of those patients who had received a previous general anaesthetic for the same procedure, 70 (93%) said they preferred the sedoanalgesic technique, two felt the methods to be equivalent and three thought general anaesthesia better.
Recovery profiles for patients in group A showed that 18% took more than 1 h to achieve full subjective awakening whilst all patients receiving flumazenil were subjectively recovered within 60 min of surgery (see Table 4 ). This difference was most significant at the 15 min time point with 83% of patients in group B awake and ready for discharge compared with just 24% in group A (P<O.OOI; with an estimated difference of 59% between the groups, the 95% confidence intervals are 42-76%).
Discussion
Anxiety is a common symptom in patients due to undergo surgery", A significant part of this is due to fear of'anaeethesia-". Other worries concern surgery, death, loss of control and the unknown". These can be effectively dealt with by means of an anxiolytic premedication and in this respect benzodiazepines prove both safe and effective 3 • 8 • 9 . In our practice of day-case surgery, midazolam is preferred to diazepam due to its shorter duration of action, reduced tissue irritation and greater amnesic potential. Postoperatively most patients will recover and be ready for discharge within 1-2 h of their procedure.
Prolonged recovery times are inconvenient with respect to bed occupancy and demands made on the level of nursing care both in theatre and on the ward.
This study demonstrates that in patients receiving a sedoanalgesic technique for day-case surgery the postoperative administration offlumazenil 0.5 mg intravenously effectively reduces patient recovery time to just a few minutes and renders them potentially ready for discharge within 15 min of return to the ward. 58 Pain scores on the visual analogue scale show minimal discomfort on intramuscular injection of midazolam, in keeping with its lack of tissue irritation. Previous studies have suggested that the use of flumazenil to facilitate recovery can lead to enhanced perception of pain in the period following surgery10. Whilst patients in group B did show a trend towards having higher postoperative pain scores than those in group A this difference did not approach statistical significance (Table 3) . A similar finding to that of Rodrigo and Rosenquist!'.
Amnesia (complete and partial) for the operative experience was in the order of 70% for both patient groups. This is in broad agreement with other studies of the amnesic potential ofmidazolam 9, 12, 13 . It also confirms there to be no retrograde facilitation of memory for the operative procedure when using flumazenil.
Whilst many procedures can be performed under local anaesthetic alone, this takes no account of the important role played by the patients emotional response to such procedures which, even with adequate analgesia, may be unpleasant or embarrassing. It is in this respect that the anxiolytic and amnesic properties of midazolam prove such a valuable adjunct to adequate local anaesthesia.
The above findings are reflected in the preference of 93% of the patients for sedoanalgesia when compared to a previous general anaesthetic and testify to the excellent patient acceptability of this technique. Such marked preference for local anaesthesia is also seen with patients undergoing cataract and dental surgery14, 15 . A preference which may be increased by the concurrent use of a benzodiazepine-".
The minimal recovery time and improved patient cooperation which attend the use of flumazenillead to the potential for enhanced patient discharge. Savings might then be achieved from the more efficient use of beds and increased patient turnover as day-cases. These are important considerations when restrictions are imposed on nursing levels!" and bed availability.
There has been concern expressed over the possibility of resedation following the administration of flumazenil given its short elimination half-life (tv.(j=:60 min). However, it must be remembered that it is tissue distribution which is the most important pharmacokinetic parameter in determining the duration of drug action following single dose administration. In this respect, midazolam and flumazenil prove not dissimilar (t'ha midazolam approximately 5-30 min, tlila flumazenil approximately 5 min). Preliminary results of a study designed to investigate this problem and which has used a psychomotor test battery to assess recovery have shown that it is not clinically significant when using the techniques outlined. These results need further verification before flumazenil facilitated early discharge can be regarded as a safe practice.
In conclusion, flumazenil safely and effectively reverses the sedative effects ofbenzodiazepines when used as indicated above. This paper suggests that the potential exists for its role to be extended from the intensive care or emergency room situation to use in day-case procedures.
